All Articles

Review Article 
Approach to the prevascular mass
Noriyuki Tomiyama
Mediastinum  
2019,  
3:
17  
Editorial Commentary 
Lymph node dissection in the left upper lobe: clinical outcomes and surgical techniques in Japan
Hiroaki Kuroda, Yusuke Sugita, Keita Nakanishi, Yukinori Sakao
Mediastinum  
2019,  
3:
16  
Editorial Commentary 
On the staging of thymic epithelial neoplasms
David Suster, Saul Suster
Mediastinum  
2019,  
3:
15  
Editorial 
Thymomas in children
Malgorzata Szolkowska
Mediastinum  
2019,  
3:
14  
Editorial Commentary 
Induction chemotherapy for locally advanced thymic epithelial tumors: consideration from the RYTHMIC prospective cohort
Kazuo Nakagawa
Mediastinum  
2019,  
3:
13  
Editorial Commentary 
WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
Mikito Suzuki, Tomoyuki Hishida, Keisuke Asakura, Hisao Asamura
Mediastinum  
2019,  
3:
12  
Editorial Commentary 
WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
Nobuyuki Takahashi, Chen Zhao, Arun Rajan
Mediastinum  
2019,  
3:
11  
Review Article 
Management of incidental anterior mediastinal lesions: summary of relevant studies
Soon Ho Yoon
Mediastinum  
2019,  
3:
9  
Original Article 
Levels of Tc17 cells in thymic epithelial cell tumors associated with autoimmune diseases
Jian Li, Yuan Chen, Yuanguo Wang, Yimei Liu, Peng Zhang
Mediastinum  
2019,  
3:
8  
Brief Report 
Radiotherapy for stage IVa thymoma—Shanghai Chest experience
Changlu Wang, Lanting Gao, Wentao Fang
Mediastinum  
2019,  
3:
7  
Review Article 
An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist’s perspective
Mirella Marino, Stefano Ascani
Mediastinum  
2019,  
3:
6  
Mini-Review 
Clinical TNM staging of thymic epithelial malignancies
Jeanne B. Ackman
Mediastinum  
2019,  
3:
5  
iMDT Corner 
Case presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team
Samantha S. Sigurdson, Anja C. Roden, Edith M. Marom, Frank C. Detterbeck, Conrad B. Falkson
Mediastinum  
2019,  
3:
4  
Letter to the Editor 
Emerging biomarkers for checkpoint inhibitors in thymic epithelial tumors
Dwight H. Owen, Gregory A. Otterson
Mediastinum  
2019,  
3:
3  
Editorial 
Survival comparison between thymic carcinoma and thymic carcinoid: does it matter in clinical practice?
Tomoyuki Hishida
Mediastinum  
2019,  
3:
2  
Editorial 
Fully-circumferential tracheal replacement: when and how?
Alain Wurtz
Mediastinum  
2019,  
3:
1  
Review Article 
The pathology of the thymus in myasthenia gravis
Alexander Marx, Philipp Ströbel, Cleo-Aron Weis
Mediastinum  
2018,  
2:
66  
Meet the Professor 
ITMIG 2018—Prof. Edith Marom: ITMIG is an innovative, young society open to all from all disciplines
Anne Lu
Mediastinum  
2018,  
2:
64  
Meet the Professor 
ITMIG 2018—Prof. Chang Hyun Kang: enthusiasm is important for a successful career
Yuehan Wang, Skylar Gao
Mediastinum  
2018,  
2:
63  
Editorial 
Investigating thymic epithelial tumor, the “source” of autoimmunity and immunodeficiency: a lesson from ITMIGRD
Liliana Montella, Margaret Ottaviano, Giovannella Palmieri
Mediastinum  
2018,  
2:
62  
Letter to the Editor 
Harnessing the power of multi-institutional databases to improve the understanding and treatment of thymic epithelial tumors
Jessica A. Hellyer, Heather A. Wakelee, Sunil S. Badve, Sukhmani K. Padda
Mediastinum  
2018,  
2:
61  
Lecture Abstract 
AB028. LA13. Management of stage IVa thymoma: Shanghai Chest experience
Changlu Wang, Lanting Gao, Wentao Fang
Mediastinum  
2018,  
2:
AB028  
Lecture Abstract 
AB027. LA12. Surgery and Intrapleural therapy for stage IVa thymic tumors
Sukki Cho
Mediastinum  
2018,  
2:
AB027